Top compounds associated with response to DNLZ


Feature Type Standardized
Nominal ANOVA
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.028 0.4
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.029 0.4
mRNA Platin CTRPv2 pan-cancer AAC -0.032 0.4
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.07 0.4
mRNA Imatinib CTRPv2 pan-cancer AAC 0.031 0.4
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.4
mRNA RG-108 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.028 0.4
mRNA sitagliptin CTRPv2 pan-cancer AAC 0.065 0.4
Download CSV